Functional Limitations In Biotechnology Risk Invalidity For Lack Of Enablement
By EsqSocial Corporation 18/02/21
On February 11, 2021, the Federal Circuit issued an opinion that suggests that inventions in fields where outcomes are unpredictable, such as biotechnology and chemistry, are more likely to lack enablement if they contain functional limitations. Amgen Inc. v. Sanofi, No. 2020-1074 (Fed. Cir. Feb. 11, 2021)......
By: Vinson & Elkins LLP